Skip Nav Destination
Issues
1 November 2008
-
Cover Image
Cover Image
In the foreground are photographic images of clinical Barrett’s esophagus (BE; top; photo courtesy of Brian J. Reid, M.D., Ph.D.) and of the histology of Barrett’s esophagus (bottom; image courtesy of Elizabeth Montgomery, M.D.). BE involves early genome-wide chromosomal deletions that progress and increase in size with increasing histopathological severity; the number of larger copy losses is significantly higher in advanced BE and esophageal adenocarcinoma compared with that in early BE lesions. See articles by Wistuba and Meyerson (beginning on page 404 and Li et al. (beginning on page 413) for more information. The background image is an Illumina BeadChip scan depicting sequence variations in several microRNA-related genes. Genetic variations within microRNAs and their processing pathways are important to esophageal cancer risk, which dramatically increases with an increasing number of variants. Genetic variants in the normal esophagus progress through microRNA pathway changes to esophageal adenocarcinoma, presumably progressing through Barrett’s esophagus prior to cancer. These findings may lead to the development of tools for identifying high-risk patients and ultimately to better prevention. See article by Ye et al. (beginning on page 460) for more information. - PDF Icon PDF LinkTable of Contents
ISSN 1940-6207
EISSN 1940-6215
Issue Sections
Editorial
Commentary
Perspective
Research Articles
Single Nucleotide Polymorphism–Based Genome-Wide Chromosome Copy Change, Loss of Heterozygosity, and Aneuploidy in Barrett's Esophagus Neoplastic Progression
Xiaohong Li; Patricia C. Galipeau; Carissa A. Sanchez; Patricia L. Blount; Carlo C. Maley; Jessica Arnaudo; Daniel A. Peiffer; Dmitry Pokholok; Kevin L. Gunderson; Brian J. Reid
Missed Adenomas during Colonoscopic Surveillance in Individuals with Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer)
Elena M. Stoffel; D. Kim Turgeon; David H. Stockwell; Lili Zhao; Daniel P. Normolle; Missy K. Tuck; Robert S. Bresalier; Norman E. Marcon; John A. Baron; Mack T. Ruffin; Dean E. Brenner; Sapna Syngal; Great Lakes-New England Clinical Epidemiology and Validation Center of the Early Detection Research Network
Gemini Vitamin D Analogues Inhibit Estrogen Receptor–Positive and Estrogen Receptor–Negative Mammary Tumorigenesis without Hypercalcemic Toxicity
Hong Jin Lee; Shiby Paul; Nadi Atalla; Paul E. Thomas; Xinjie Lin; Ill Yang; Brian Buckley; Gang Lu; Xi Zheng; You-Rong Lou; Allan H. Conney; Hubert Maehr; Luciano Adorini; Milan Uskokovic; Nanjoo Suh
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.